I. Cánovas Olmos

492 total citations
13 papers, 104 citations indexed

About

I. Cánovas Olmos is a scholar working on Psychiatry and Mental health, Toxicology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, I. Cánovas Olmos has authored 13 papers receiving a total of 104 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Psychiatry and Mental health, 3 papers in Toxicology and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in I. Cánovas Olmos's work include Schizophrenia research and treatment (4 papers), Pharmacovigilance and Adverse Drug Reactions (3 papers) and Epilepsy research and treatment (2 papers). I. Cánovas Olmos is often cited by papers focused on Schizophrenia research and treatment (4 papers), Pharmacovigilance and Adverse Drug Reactions (3 papers) and Epilepsy research and treatment (2 papers). I. Cánovas Olmos collaborates with scholars based in Uruguay, Spain and United States. I. Cánovas Olmos's co-authors include Marta Vázquez, Pietro Fagiolino, Manuel Ibarra, Cecilia Maldonado, Gustavo Giachetto, Georgios Schoretsanitis, José de León, Edoardo Spina, Miloslav Kopeček and Emílio J. Sanz and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Schizophrenia Research.

In The Last Decade

I. Cánovas Olmos

7 papers receiving 101 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. Cánovas Olmos Uruguay 5 73 35 12 12 11 13 104
Ashley Brenton United States 6 22 0.3× 24 0.7× 16 1.3× 16 1.3× 11 85
Gema Requena Spain 5 24 0.3× 38 1.1× 6 0.5× 18 1.5× 16 1.5× 7 83
C. Greiner Germany 5 30 0.4× 15 0.4× 42 3.5× 17 1.4× 1 0.1× 10 96
J.O.B. Olubodun United States 4 14 0.2× 14 0.4× 22 1.8× 19 1.6× 13 1.2× 6 112
Jürgen Hallbach Germany 6 11 0.2× 23 0.7× 12 1.0× 9 0.8× 21 1.9× 12 91
Allison A. Muller United States 5 22 0.3× 14 0.4× 19 1.6× 4 0.3× 26 2.4× 17 106
Christopher Hyson Canada 5 18 0.2× 20 0.6× 53 4.4× 5 0.4× 30 2.7× 7 106
Benedikt Stegmann Germany 11 154 2.1× 47 1.3× 59 4.9× 71 5.9× 7 0.6× 17 231
Leonor Laredo Spain 5 27 0.4× 11 0.3× 9 0.8× 4 0.3× 10 0.9× 14 109
Luc Sauriol Canada 10 29 0.4× 25 0.7× 22 1.8× 3 0.3× 24 355

Countries citing papers authored by I. Cánovas Olmos

Since Specialization
Citations

This map shows the geographic impact of I. Cánovas Olmos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Cánovas Olmos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Cánovas Olmos more than expected).

Fields of papers citing papers by I. Cánovas Olmos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Cánovas Olmos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Cánovas Olmos. The network helps show where I. Cánovas Olmos may publish in the future.

Co-authorship network of co-authors of I. Cánovas Olmos

This figure shows the co-authorship network connecting the top 25 collaborators of I. Cánovas Olmos. A scholar is included among the top collaborators of I. Cánovas Olmos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Cánovas Olmos. I. Cánovas Olmos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Baptista, Trino, I. Cánovas Olmos, J.G. Yépez, et al.. (2023). An expert review of clozapine in Latin American countries: Use, monitoring, and pharmacovigilance. Schizophrenia Research. 268. 60–65. 7 indexed citations
2.
Baptista, Trino, et al.. (2023). Clozapine safety monitoring and related research in psychiatry and neurology in South America: A scoping review. Schizophrenia Research. 268. 29–33. 4 indexed citations
3.
Ortíz-Sanjuán, F., Carmen Bárcena, José E. Rodríguez, et al.. (2023). AB0928 USE OF RITUXIMAB IN SYSTEMIC SCLEROSIS PATIENTS WITH PULMONARY AND DIFFUSE CUTANEOUS INVOLVEMENT. A SERIES OF 15 CASES. Annals of the Rheumatic Diseases. 82. 1681–1681.
4.
Bárcena, Carmen, I. Cánovas Olmos, J. Ivorra Cortés, et al.. (2023). AB1587 EXPERIENCE IN REAL-WORLD CONDITIONS OF THE EFFECTIVENESS OF THE VACCINE AGAINST HERPES ZOSTER. Annals of the Rheumatic Diseases. 82. 2027–2028.
5.
Olmos, I. Cánovas, et al.. (2022). Depresión: más allá del mito de la serotonina.. 86(2).
6.
Schoretsanitis, Georgios, Robert L. Smith, Espen Molden, et al.. (2021). European Whites May Need Lower Minimum Therapeutic Clozapine Doses Than Those Customarily Proposed. Journal of Clinical Psychopharmacology. 41(2). 140–147. 19 indexed citations
7.
Olmos, I. Cánovas, Manuel Ibarra, Marta Vázquez, et al.. (2019). Population Pharmacokinetics of Clozapine and Norclozapine and Switchability Assessment between Brands in Uruguayan Patients with Schizophrenia. BioMed Research International. 2019. 1–10. 26 indexed citations
8.
Cortés, J. Ivorra, et al.. (2017). SAT0697 Prevalence of hepatitis b and c infection and reactivation in patients receiving biologic iv therapies. Annals of the Rheumatic Diseases. 76. 1039–1039. 1 indexed citations
9.
Olmos, I. Cánovas, et al.. (2015). Consumo de benzodiazepinas en la población uruguaya: un posible problema de salud pública. Americanae (AECID Library). 31(2). 112–119. 7 indexed citations
10.
Olmos, I. Cánovas, et al.. (2015). Consumo de benzodiazepinas en la población uruguaya. SHILAP Revista de lepidopterología. 31(2). 112–119.
11.
Vázquez, Marta, et al.. (2014). Hyperammonemia Associated with Valproic Acid Concentrations. BioMed Research International. 2014. 1–7. 39 indexed citations
12.
Olmos, I. Cánovas, et al.. (2008). Uso de metilfenidato en niños y adolescentes usuarios de servicios de asistencia pública de Montevideo. Americanae (AECID Library). 79(4). 277–283.
13.
Olmos, I. Cánovas, et al.. (2007). Hospitalisations for Adverse Drugs Reactions in a Health Maintenance Organisation in Montevideo (Uruguay). Drug Safety. 30(10). 919–990. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ashley Brenton Breakdown of academic impact, for papers by Gema Requena Breakdown of academic impact, for papers by C. Greiner Breakdown of academic impact, for papers by J.O.B. Olubodun Breakdown of academic impact, for papers by Jürgen Hallbach Breakdown of academic impact, for papers by Allison A. Muller Breakdown of academic impact, for papers by Christopher Hyson Breakdown of academic impact, for papers by Benedikt Stegmann Breakdown of academic impact, for papers by Leonor Laredo Breakdown of academic impact, for papers by Luc Sauriol
Rankless by CCL
2026